The tricuspid valve device market has “exploded” of late with waves of new innovators entering the field, a surge that has not gone unnoticed by Dr. Hendrik Treede, director of the Department of Cardiac and Vascular Surgery at the University Hospital Mainz, Germany.
Long known as “the forgotten valve,” the tricuspid valve has gained attention following the US Food and Drug Administration’s approval of two devices last year, Edwards Lifesciences' tricuspid valve replacement...